Stephens raised the firm’s price target on Ensign Group (ENSG) to $170 from $165 and keeps an Overweight rating on the shares. Despite Ensign contending with uncertainty surrounding the long-term Medicaid reimbursement backdrop for Skilled Nursing Facilities, fundamentals “have not wavered,” says the analyst, who raises estimates following the company’s Q2 report.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENSG:
